Research
The Myhrvold lab develops CRISPR-based technologies for studying RNA. Our primary interest is RNAs involved in host-pathogen interactions. We use a variety of RNA viruses and other pathogens as model systems. In collaboration with others, we also apply our technologies in a diverse array of biological contexts.
Cas13-based technologies to perturb and readout RNA dynamics
CRISPR-Cas9 has revolutionized our ability to study and manipulate genomic information. Developing Cas13-based technologies can revolutionize the way we study and manipulate RNA. We are developing a variety of Cas13-based technologies to perturb and readout RNA in high throughput. We work closely with colleagues in the Molecular Biology department to apply our new technologies to study diverse biological problems. Our work will advance the field of RNA biotechnology, allowing us to unlock the secrets of gene expression, regulation, and function.